Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Richter

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
The Cochrane Database of Systematic Reviews|November 2, 2016
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusBianca Hemmingsen, David Peick Sonne, Maria-Inti Metzendorf, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 27, 2005
[Patient participation in the Cochrane Collaboration--barriers, experience, and concepts in Germany]Olaf Weingart, Nicole Skoetz, Britta Lang, et al.
The Cochrane Database of Systematic Reviews|May 11, 2017
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitusBianca Hemmingsen, David P Sonne, Maria-Inti Metzendorf, et al.
BMC Medical Research Methodology|December 20, 2018
Study filters for non-randomized studies of interventions consistently lacked sensitivity upon external validationElke Hausner, Maria-Inti Metzendorf, Bernd Richter, et al.
American Journal of Epidemiology|July 27, 2002
Body weight, blood pressure, and mortality in a cohort of obese patientsRalf Bender, Karl-Heinz Jöckel, Bernd Richter, et al.
The Cochrane Database of Systematic Reviews|December 4, 2019
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusKasper S Madsen, Yuan Chi, Maria-Inti Metzendorf, et al.
BMC Rheumatology|December 9, 2022
A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritisKirsten Janke, Corinna Kiefer, Natalie McGauran, et al.
Systematic Reviews|September 11, 2022
Screw fixation in the treatment of displaced intra-articular calcaneus fractures: a systematic review protocolLeah Wilmsen, Anne Neubert, Joachim Windolf, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 6, 2023
Incidence of Stroke in People With Diabetes Compared to Those Without Diabetes: A Systematic ReviewTatjana Kvitkina, Maria Narres, Heiner Claessen, et al.
Diabetes/Metabolism Research and Reviews|March 13, 2020
Incidence of stroke in the diabetic compared with the non-diabetic population: A systematic review protocolTatjana Kvitkina, Maria Narres, Heiner Claessen, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
The Cochrane Database of Systematic Reviews|November 2, 2016
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusBianca Hemmingsen, David Peick Sonne, Maria-Inti Metzendorf, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 27, 2005
[Patient participation in the Cochrane Collaboration--barriers, experience, and concepts in Germany]Olaf Weingart, Nicole Skoetz, Britta Lang, et al.
The Cochrane Database of Systematic Reviews|May 11, 2017
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitusBianca Hemmingsen, David P Sonne, Maria-Inti Metzendorf, et al.
BMC Medical Research Methodology|December 20, 2018
Study filters for non-randomized studies of interventions consistently lacked sensitivity upon external validationElke Hausner, Maria-Inti Metzendorf, Bernd Richter, et al.
American Journal of Epidemiology|July 27, 2002
Body weight, blood pressure, and mortality in a cohort of obese patientsRalf Bender, Karl-Heinz Jöckel, Bernd Richter, et al.
The Cochrane Database of Systematic Reviews|December 4, 2019
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitusKasper S Madsen, Yuan Chi, Maria-Inti Metzendorf, et al.
BMC Rheumatology|December 9, 2022
A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritisKirsten Janke, Corinna Kiefer, Natalie McGauran, et al.
Systematic Reviews|September 11, 2022
Screw fixation in the treatment of displaced intra-articular calcaneus fractures: a systematic review protocolLeah Wilmsen, Anne Neubert, Joachim Windolf, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 6, 2023
Incidence of Stroke in People With Diabetes Compared to Those Without Diabetes: A Systematic ReviewTatjana Kvitkina, Maria Narres, Heiner Claessen, et al.
Diabetes/Metabolism Research and Reviews|March 13, 2020
Incidence of stroke in the diabetic compared with the non-diabetic population: A systematic review protocolTatjana Kvitkina, Maria Narres, Heiner Claessen, et al.
Pageof 5